The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive

Author： Zimmerman Yvette   Coelingh Bennink Herjan J. T.   Wouters Wout   Ebes Frieda   Fauser Bart C. J. M.  

Publisher： Informa Healthcare

ISSN： 1473-0782

Source： The European Journal of Contraception and Reproductive Health Care, Vol.18, Iss.6, 2013-12, pp. : 489-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of an oral contraceptive containing drospirenone in an extended regimen

By Sillem M.   Schneidereit R.   Heithecker R.   Mueck A. O.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 3, 2003-09 ,pp. : 162-169

Informa Healthcare

Access to resources Recommend Favorite

The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone

By Zimmerman Yvette   Wouters Wout   Coelingh Bennink Herjan J. T.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 3, 2013-06 ,pp. : 206-214

Informa Healthcare

Access to resources Recommend Favorite

Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms

By Apter D.   Borsos A.   Baumgärtner W.   Melis G.-B.   Vexiau-Robert D.   Colligs-Hakert A.   Palmer M.   Kelly S.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 1, 2003-03 ,pp. : 37-51

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen

By Mansour Diana   Verhoeven Carole   Sommer Werner   Weisberg Edith   Taneepanichskul Surasak   Melis Gian Benedetto   Sundström-Poromaa Inger   Korver Tjeerd  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 6, 2011-12 ,pp. : 430-443

Informa Healthcare

Access to resources Recommend Favorite

Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

By Endrikat J.   Gerlinger C.   Cronin M.   Wessel J.   Ruebig A.   Rosenbaum P.   Düsterberg B.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 4, 2001-12 ,pp. : 199-204

Informa Healthcare

Access to resources Recommend Favorite